A Day Up For Aravive, Inc.

Wed, Aug 30, 2023 at 07:07 PM

Aravive, Inc. (ARAV:NASDAQ) jumped higher at $0.17, representing a gain of 46.1%. The stock got featured on our News Catalysts scanner on Wed, Aug 02, 2023 at 04:53 PM in the 'BIOTECH' category. From Wed, Aug 16, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Tue, Mar 21, 2023 at $2.46 with a volume of 1M+.

About Aravive, Inc. (ARAV:NASDAQ)

Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.

Top 10 Gainers:

AgileThought Inc. (AGIL:NASDAQ), 83.03%
IronNet Inc. (IRNT:NYSE), 75%
Tingo Group Inc Com (TIO:NASDAQ), 64.76%
F45 Training Holdings Inc. (FXLV:NYSE), 60%
Greenland Technologies Holding Corporation (GTEC:NASDAQ), 56.65%
Aravive, Inc. (ARAV:NASDAQ), 46.12%
AEON Biopharma Inc. Class A (AEON:NYSEMKT), 42.29%
SeqLL Inc. (SQL:NASDAQ), 40.8%
PAVmed Inc. (PAVM:NASDAQ), 35.76%
Digital Brands Group Inc. (DBGI:NASDAQ), 34.83%